Unknown

Dataset Information

Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population.


ABSTRACT:

Background

The adaptive immune response is a crucial component of the protective immunity against SARS-CoV-2, generated after infection or vaccination.

Methods

We studied antibody titers, neutralizing antibodies and cellular immune responses to four different COVID-19 vaccines, namely Pfizer-BioNTech, Moderna Spikevax, AstraZeneca and Sinopharm vaccines in the Bangladeshi population (n = 1780).

Results

mRNA vaccines Moderna (14,655 ± 11.3) and Pfizer (13,772 ± 11.5) elicited significantly higher anti-Spike (S) antibody titers compared to the Adenovector vaccine AstraZeneca (2443 ± 12.8) and inactivated vaccine Sinopharm (1150 ± 11.2). SARS-CoV-2-specific neutralizing antibodies as well as IFN-γ-secreting lymphocytes were more abundant in Pfizer and Moderna vacc

SUBMITTER: Sarker P 

PROVIDER: S-EPMC9504987 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature